Mode
Text Size
Log in / Sign up
N/A N=52 Randomized Single-blind Other

Impact of Catheter Size on Peri-Operative Pain After Robotic Assisted Laparoscopic Prostatectomy

Prostate Cancer

Enrolled (actual)
52
Serious AEs
0.0%
Results posted
Dec 2019
Primary outcome: Primary: Catheter Related Pain: Visual Analog Score Rating — 2.67; 2.67 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
16 French urinary catheter (Device); 20 French urinary catheter (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
Male
Sponsor
Benaroya Research Institute
Primary completion
Nov 2018

Outcome Measures

OutcomeResultp-value
PRIMARY
Catheter Related Pain: Visual Analog Score Rating
2.67; 2.67
SECONDARY
Urinary Symptoms
6.52; 7.59
SECONDARY
Quality of Life Score
2.24; 2.29
SECONDARY
Urinary Symptoms
6.52; 7.59
SECONDARY
Quality of Life Score
2.24; 2.29
SECONDARY
Opioid Use
5.00; 4.48
SECONDARY
Home Opioid Use in Standard Morphine Equivalency
37.50; 33.57
SECONDARY
Number of Incontinence Pads Used
2.00; 1.79
SECONDARY
Patient Reported Number of Pads Used Per Day.
1.17; 1.13
SECONDARY
Number of Participants Experiencing Bladder Neck Contracture
0; 1
SECONDARY
Number of Participants Experiencing Bladder Neck Contracture
0; 1

Summary

This study is designed to assess the effect of catheter size on postoperative catheter pain, urinary continence, urinary flow rates, post void residuals, International Prostate Symptom Scores (IPSS), and Quality of Life (QoL) score, as well as long term complications after robotic assisted laparoscopic prostatectomy.

Eligibility Criteria

Inclusion Criteria

  • Identified as candidate for robotic assisted laparoscopic prostatectomy

Exclusion Criteria

  • Having filled a prescription for opioid medication in last 2 months.
  • Known latex allergy
  • Known pre-operatively that catheter placement will exceed 14 days
  • History of pelvic radiation
  • Significant deviation from normal operative protocol
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04098809). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search